Suppression of the FA pathway combined with CHK1 inhibitor hypersensitize lung cancer cells to gemcitabine
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-017-15172-4.pdf
Reference48 articles.
1. Torre, L. A., Siegel, R. L., Ward, E. M. & Jemal, A. Global cancer incidence and mortality rates and trends-an update. Cancer Epidemiol Biomarkers Prev. 25, 16–27 (2015).
2. Travis, W. D. Pathology of lung cancer. Clin Chest Med. 32, 669–692 (2011).
3. Massarelli, E. & Herbst, R. S. Use of novel second-line target therapies in non-small cell lung cancer. Semin Oncol. 33(suppl 1), s9–s16 (2006).
4. Raparia, K., Villa, C., DeCamp, M. M., Patel, J. D. & Mehta, M. P. Molecular profiling in non-small cell lung cancer: a step toward personalized medicine. Arch Pathol Lab Med. 137, 481–491 (2013).
5. Minguet, J., Smith, K. H. & Bramlage, P. Targeted therapies for treatment of non-small cell lung cancer Recent advances and future perspectives. Int J Cancer. 138, 2549–2561 (2016).
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinoma;British Journal of Cancer;2022-12-16
2. Fanconi anemia proteins and genome fragility: unraveling replication defects for cancer therapy;Trends in Cancer;2022-06
3. Centipeda minima extract sensitizes lung cancer cells to DNA-crosslinking agents via targeting Fanconi anemia pathway;Phytomedicine;2021-10
4. First molecular cytogenetic characterisation of tracheal squamous cell carcinoma cell line KLN 205;Journal of Cancer Metastasis and Treatment;2021
5. Inhibition of DNA Repair in Cancer Therapy: Toward a Multi-Target Approach;International Journal of Molecular Sciences;2020-09-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3